IRCT2016111530905N1已完成3 期
¬¬A randomized double blind placebo controlled trial examining the effects of Pentoxifylline on Contrast Induced Nephropathy reduction after percutaneous coronary intervention in high risk candidates
Imam Hossein Hospital0 个研究点目标入组 110 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Inclusion criterion was only Mehran score more than or equal to 11. Exclusion criteria included need for urgent coronary angiography in the first 48 hours after admission, history of contrast media usage in previous 14 days or renal failure in recent six months, multiple myeloma, pregnancy or breastfeeding and pre-planned use of any other measure for CIN prevention apart from PTX consumption.
排除标准
- 未提供
研究者
相似试验
尚未招募
3 期
A Randomized Double-blinded Placebo-controlled Trial of Prophylactic Rectal Indomethacin for Prevention of Post-embolization Syndrome in Patients with Hepatocellular CarcinomaPost-embolization syndromeRectal indomethacinTACEInterleukin-6Interleukin-13TNF-alphaICAM-1Hepatocellular carcinomaTCTR20210209002In process for Ratchadaphiseksomphot Endowment Fund submission120
招募中
Unknown
effects of melatonin as premedication agent in caesarean sectioEfficacy of melatonin to patient with caesarian section under spinal anesthesia with ASA I and ASA II.F06.4anxietyIRCT20230809059105N1Alayen universty80
尚未招募
4 期
A study to observe the effect of therapeutic doses of Diazepam among healthy individuals using stop signal reaction timeCTRI/2020/02/023530Institute of Neurosciences Kolkata
已完成
3 期
Ayurvedic formulation in the management of COVID patients in rural IndiaCTRI/2021/10/037442Sriveda Sattva Pvt Ltd100
已完成
不适用
A Randomised Placebo - Controlled Double Blind Trial Comparing 1) a Two Month Intensive Phase of Ethambutol, Moxifloxacin, Rifampicin, Pyrazinamide Versus the Standard Regimen (Ethambutol, Isoniazid, Rifampicin, Pyrazinamide) and 2) a Treatment Shortening Regimen Comparing Two Months Moxifloxacin, Isoniazid, Rifampicin, Pyrazinamide Followed by Two Months Moxifloxacin, Isoniazid, Rifampicin Versus the Standard Regimen (Two Months Ethambutol, Isoniazid, Rifampicin, Pyrazinamide Followed by Four Months Isoniazid and Rifampicin) for the Treatment of Adults With Pulmonary Tuberculosis-A15 Respiratory tuberculosis, bacteriologically and histologically confirmedRespiratory tuberculosis, bacteriologically and histologically confirmedA15PER-098-09niversity College London,